Drug Profile
Typhoid vaccine oral - Acambis
Alternative Names: CVD 908-htrA; HolaVax-TyphoidLatest Information Update: 12 Oct 2006
Price :
$50
*
At a glance
- Originator Acambis
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Typhoid
Most Recent Events
- 12 Oct 2006 Discontinued - Phase-II for Typhoid in USA (PO)
- 12 May 2004 Suspended - Phase-II for Typhoid in USA (PO)
- 05 Feb 2004 The HolaVax-Typhoid vaccine is available for licensing (http://www.acambis.com)